Day: January 7, 2021

EJ FÖR OFFENTLIGGÖRANDE, PUBLICERING ELLER DISTRIBUTION, DIREKT ELLER INDIREKT, I ELLER TILL USA, AUSTRALIEN, JAPAN ELLER KANADA ELLER I NÅGON ANNAN JURISDIKTION DÄR DISTRIBUTION AV DETTA PRESSMEDDELANDE SKULLE VARA OLAGLIG ELLER KRÄVA REGISTRERING ELLER ANDRA ÅTGÄRDER UTÖVER VAD SOM FÖLJER AV SVENSK RÄTT.  Enligt den tidigare kommunicerade tidplanen för Active Biotechs företrädesemission skulle handeln i teckningsrätter (TR) och betalda tecknade aktier (BTA) inledas idag den 7 januari 2021. Av tekniska skäl kommer handel istället inledas imorgon, den 8 januari 2021. Med undantag för detta görs inga andra justeringar i den tidigare kommunicerade tidplanen.Lund den 7 januari 2021För ytterligare information, vänligen kontakta:Helén Tuvesson, Verkställande DirektörTel. 046 19 21 56Hans Kolam, CFOTel. 046 19 20 44Active Biotech AB (publ)...

Paris, France – January 7, 2021 – Following recent market rumors about a potential transaction involving Atos, the Company confirms that it has approached DXC Technology concerning a potential friendly transaction between the two groups in order to create a Digital Services Leader benefitting from global scale, talent and innovation. In assessing this opportunity, Atos will apply the financial discipline which it has always followed in its acquisition strategy. There can be no certainty at this stage that this approach will result in any agreement or transaction. Further announcement will be made when appropriate.ContactsInvestor Relations:               Gilles Arditti                 +33 6 11 69 81 74                                                                                    gilles.arditti@atos.netMedia:                                   ...

Paris, France – 7 janvier 2021 – Suite aux récentes rumeurs de marché concernant une transaction potentielle impliquant Atos, la société confirme avoir approché DXC Technology concernant une transaction amicale potentielle entre les deux groupes afin de créer un leader des Services Digitaux bénéficiant d’une envergure mondiale, et combinant leurs talents et capacité d’innovation respectives. Dans l’évaluation de cette opportunité, Atos appliquera la discipline financière qu’il a toujours respectée dans sa stratégie d’acquisitions. À ce stade, il n’existe aucune certitude que cette approche débouchera sur un accord ou une transaction. La société communiquera ultérieurement en tant que de besoin.ContactsRelations Investisseurs :     Gilles Arditti                 +33 6 11 69 81 74                                                          ...

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATESTORONTO, Jan. 07, 2021 (GLOBE NEWSWIRE) — Water Ways Technologies Inc. (TSXV: WWT) (“Water Ways” or the “Company“), is pleased to announce that, it has received orders totaling over CDN$3 Million, since October, 2020 of which CDN$1.8 Million have not been previously disclosed.The orders received included:Orders for agricultural and irrigation supplies from customers in Canada and the U.S. totaling over CDN$2.4 Million of which CDN$1.2 Million have not been previously disclosed; andOrders for irrigation products from a distributor in Peru totaling over CDN$0.6 Million.Water Ways expects to recognize most of the revenue from these orders in Q1 of 2021.“I am extremely pleased to watch our order backlog for 2021 increase...

BOSTON, Jan. 07, 2021 (GLOBE NEWSWIRE) — X4 Pharmaceuticals, Inc. (Nasdaq: XFOR), a leader in the discovery and development of novel therapies targeting diseases resulting from dysfunction of the CXCR4 pathway, today announced that management will present at the H.C. Wainwright Virtual BioConnect Conference being held from January 11-14, 2021.   A webcast of the on-demand presentation will be available on the investor section of the X4 Pharmaceuticals website at www.x4pharma.com and at Presentation Webcast Link, beginning on Monday, January 11, 2021.Following the conclusion of the conference, the event will remain archived on the X4 Pharmaceuticals’ website for approximately 90 days.About X4 PharmaceuticalsX4 Pharmaceuticals is a late-stage clinical biopharmaceutical company and a leader in the discovery and development of novel...

SPOKANE, Wash., Jan. 07, 2021 (GLOBE NEWSWIRE) — Kaspien (NASDAQ: KSPN) and Levin Consulting today announced a new partnership focused on providing consumer brands with industry-leading omni-channel strategy and services for both online marketplaces like Amazon and traditional retailers.Kaspien is the leading ecommerce software and services provider for emerging and billion-dollar brands. With over 12 years of experience serving over 4,000 brands on Amazon, Walmart, and other major online marketplaces, Kaspien’s robust platform provides industry-leading services for digital marketing, inventory and supply chain management, brand protection, and more.Levin Consulting has spent the past 33 years servicing consumer technology brands in the retail sector. Their focus has been on developing and executing strategies for profitable and...

MINNEAPOLIS, Jan. 07, 2021 (GLOBE NEWSWIRE) — Northern Technologies International Corporation (NASDAQ: NTIC), a leading developer of corrosion inhibiting products and services, as well as bio-based and biodegradable polymer resin compounds, today reported its financial results for the first quarter of fiscal 2021.First quarter fiscal 2021 financial and operating highlights include (with growth rates compared to first quarter of fiscal 2020, except as otherwise noted):Consolidated net sales decreased 12.7% to $12,779,000, and up 27.4% over fourth quarter of fiscal 2020ZERUST® net sales increased 2.7% to $9,078,000ZERUST® oil and gas net sales increased 8.0% to $563,000NTIC China net sales increased 17.7% to a quarterly record $4,544,000Natur-Tec® product net sales decreased 45.4% to $2,559,000Joint venture operating income increased...

CINCINNATI, Jan. 07, 2021 (GLOBE NEWSWIRE) — LSI Industries Inc. (NASDAQ: LYTS, or the “Company”), a leading U.S. based manufacturer of indoor/outdoor lighting and graphics solutions, today announced that it will release second quarter fiscal 2021 results before the market opens on Thursday, January 21, 2021. A conference call will be held that same day at 11:00 a.m. ET to review the Company’s financial results, discuss recent events and conduct a question-and-answer session.A webcast of the conference call and accompanying presentation materials will be available in the Investor Relations section of LSI Industries’ website at www.lsicorp.com. Individuals can also participate by teleconference dial-in. To listen to a live broadcast, go to the site at least 15 minutes prior to the scheduled start time in order to register, download...

MONTREAL, Jan. 07, 2021 (GLOBE NEWSWIRE) — Nuvei Corporation (“Nuvei” or the “Company”) (TSX: NVEI and NVEI.U), the global payment technology partner of thriving brands, today announced that the Company will be participating in the following virtual investor conferences in January 2021.Goldman Sachs 2021 Virtual Technology & Internet Conference on Tuesday, January 12, 2021.23rd Annual Needham Virtual Growth Conference on Thursday, January 14, 2021.About NuveiWe are Nuvei, the payment technology partner of thriving brands. We provide the intelligence and technology businesses need to succeed locally and globally, through one integration – propelling them further, faster. Uniting payment technology and consulting, we help businesses remove payment barriers, optimize operating costs and increase acceptance rates. Our proprietary...